ST Pharm is trading at 65,100 KRW as of 10:30 AM on the 31st, up 0.93% from the previous day. The trading volume is 214,742 shares, which is 33.14% of the previous day's volume. ST Pharm is known as a company specializing in active pharmaceutical ingredients.


On August 28, Samsung Securities researcher Seo Geun-hee stated, "The recently announced oligo factory expansion is estimated at 800kg, up from the previous estimate of 500kg, leading to an upward revision of the target stock price. The expansion decision was made due to increased CMO demand from the development of oligo therapeutics and the use of oligos as immune boosters for COVID-19 vaccines, resulting in capacity expansion. Expectations for new orders and additional expansions remain valid." He set the target price for ST Pharm at 80,000 KRW.


Over the past five days, individual investors have net purchased 27,628 shares of ST Pharm, while foreigners and institutions have net sold 72,558 shares and net purchased 19,116 shares, respectively.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing